Peter Wersäll

5.4k citations
68 papers · 3.7k · 1 hit paper · h-index 25

Impact in

  • Surgery top 1%
    • Bladder and Urothelial Cancer Treatments
    • Urinary and Genital Oncology Studies
    • Management of metastatic bone disease
    • Renal cell carcinoma treatment
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Renal cell carcinoma treatment 13
    • Lung Cancer Diagnosis and Treatment 5
    • Immunotherapy and Immune Responses 10
    • Immune Cell Function and Interaction 8
    • T-cell and B-cell Immunology 7

Peter Wersäll

67 papers receiving 3.6k citations

Peter Wersäll's Hit Papers

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study 2000 · 1.7k citations
1.7k0+8+17Years since publication50010001.5k

Peers

Peter Wersäll
Comparison fields: 5 of 95
  • Surgery 1.6k
  • Pulmonary and Respiratory Medicine 1.0k
  • Oncology 799
  • Radiation 233
  • Urology 106
Replace Lisa Sengeløv with:
Lisa Sengeløv Denmark
Nevin Murray Canada
Haakon Ragde United States
Wesley C. Fowler United States
Sandra Collette Belgium
Scott Saxman United States
Paul B. Gaudin United States
Claus Kamby Denmark
Renzo Corvò Italy
Anna Pacelli United States
Peter Wersäll relative to Lisa Sengeløv Denmark Lisa Sengeløv's profile →
Citations per field
00.5×2.6×
Lisa Sengeløv · 1×
Citations per year

Countries citing papers authored by Peter Wersäll

Since Specialization
Citations

This map shows the geographic impact of Peter Wersäll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wersäll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wersäll more than expected).

Fields of papers citing papers by Peter Wersäll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wersäll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wersäll. The network helps show where Peter Wersäll may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Wersäll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Wersäll Line = papers co-authored together Peter Wersäll links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Hit paper breakdown →
20001701
2 2005157
3 2004149
4 2006131
5 2003120
6 2003118
7 2000102
8 201193
9 200868
10 199762
11 201560
12
The therapeutic use of monoclonal antibodies in colorectal carcinoma.
199156
13 201655
14 201854
15 200546
16 199046
17 200043
18 199843
19 200541
20 200241

About Peter Wersäll

Peter Wersäll is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Radiology, Nuclear Medicine and Imaging, Oncology and Radiation, having authored 68 papers that have together received 3.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (13 papers), Immunotherapy and Immune Responses (10 papers), Advanced Radiotherapy Techniques (9 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Surgery (1.6k citations), Pulmonary and Respiratory Medicine (1.0k citations), Oncology (799 citations), Radiation (233 citations) and Urology (106 citations). Peter Wersäll has collaborated with scholars based in Sweden, Netherlands and Denmark. Frequent co-authors include Hans von der Maase, Steen Werner Hansen, D. Roychowdhury, Luigi Dogliotti, Peter Albers, Malcolm J. Moore, Alexander Knuth, J.T. Roberts, I. Bodrogi and Pierre Kerbrat. Their work appears in journals such as Acta Oncologica, International Journal of Radiation Oncology*Biology*Physics, Cancer Immunology Immunotherapy, Radiotherapy and Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact